Clinical trials show average weight loss of 6-8% of body weight after 3 months on semaglutide 2.4mg (Wegovy). For a 220-pound person, this represents approximately 13-18 pounds. By the 3-month mark, most patients have reached the 1.0mg or 1.7mg dose level following standard titration protocols. Real-world results often match or exceed clinical trial data, with some patients losing 10-15% by month 3 if they tolerate rapid titration well. Weight loss typically accelerates during months 2-4 as higher therapeutic doses are reached. Patients who also implement dietary modifications and increase physical activity may see greater results than medication alone.
Find a qualified GLP-1 provider
Compare pricing, clinical oversight, and patient reviews across verified telehealth programs and local clinics.
Compare Providers →Still have questions?
A qualified GLP-1 provider can give you personalized answers based on your medical history and goals.
Get answers to your GLP-1 questions
Weekly updates with the latest research, pricing changes, and expert guidance — delivered to your inbox.
No spam. Unsubscribe anytime.
Ready to start your GLP-1 journey?
Compare verified providers on pricing, medication sourcing, clinical oversight, and patient reviews — all in one place.